In vitro and in vivo anti-tumor effects of novel Span 80 vesicles containing immobilized Eucheuma serra agglutinin

International Journal of Pharmaceutics

Volumn 389, Issue 1-2, 2010, Pages 157-167

  Omokawa, Yousuke ^a   Miyazaki, Tatsuhiko ^b   Walde, Peter ^c   Akiyama, Koichi ^a   Sugahara, Takuya ^a   Masuda, Seizo ^a   Inada, Akihiro ^d   Ohnishi, Yasuyuki ^e   Saeki, Toshiaki ^f   Kato, Keiichi ^a  

^a EHIME UNIVERSITY   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c ETH ZURICH   (Switzerland)

^d Yamaki Co Ltd   (Japan)

^e CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^f SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

Author keywords

Agglutinin; Drug delivery; Lectin; Liposome; Nonionic; Span; Vesicle

Indexed keywords

EUCHEUMA SERRA AGGLUTININ; HEMAGGLUTININ; SORBITAN OLEATE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; DRUG BINDING; DRUG DELIVERY SYSTEM; EUCHEUMA SERRA; HEMAGGLUTINATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; RED ALGA;

ALGAE, RED; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DRUG DELIVERY SYSTEMS; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HEMAGGLUTINATION TESTS; HEXOSES; HUMANS; LECTINS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; PARTICLE SIZE; SURFACE-ACTIVE AGENTS;

EID: 77349110168     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.01.033     Document Type: Article

References (45)

1. Allen T.M. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends Pharmacol. Sci. 15 (1994) 215-220
2. Allen T.M., and Cullis P.R. Drug delivery systems: entering the mainstream. Science 303 (2004) 1818-1822
3. Barenholz Y. Liposome application: problems and prospects. Curr. Opin. Colloid Interface Sci. 6 (2001) 66-77
4. Couvreur P., and Vauthier C. Nanotechnology: intelligent design to treat complex disease. Pharm. Res. 23 (2006) 1417-1449
5. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 5 (2005) 161-171
6. Forssen E., and Willis M. Ligand-targeted liposomes. Adv. Drug Deliv. Rev. 29 (1998) 249-271
7. Foulon C.F., Reist C.J., Bigner D.D., and Zalutsky M.R. Radioiodination via d-amino acid peptide enhances cellular retention and tumor xenograft targeting of an internalizing anti-epidermal growth factor receptor variant III monoclonal antibody. Cancer Res. 60 (2000) 4453-4460
8. Fukuda Y., Sugahara T., Ueno M., Fukuta Y., Ochi Y., Akiyama K., Miyazaki T., Masuda S., Kawakubo A., and Kato K. The anti-tumor effect of Euchema serra agglutinin on colon cancer cells in vitro and in vivo. Anti-Cancer Drugs 17 (2006) 943-947
9. Gabizon A., Goren D., Horowitz A.T., Tzemach D., Lossos A., and Siegal T. Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing mice. Adv. Drug Deliv. Rev. 24 (1997) 337-344
10. Garg A., Tisdale A.W., Haidari E., and Kokkoli E. Targeting colon cancer cells using PEGylated liposomes modified with a fibrionectin-mimetic peptide. Int. J. Pharm. 366 (2009) 201-210
11. Gortzi O., Antimisiaris S.G., Klepetsanis P., Papadimitriou E., and Ioannou P.V. Arsenoliposomes: effect of arsenolipid acyl chain length and vesicle composition on their toxicity towards cancer and normal cells in culture. Eur. J. Pharm. Sci. 18 (2003) 175-183
12. 125I-labelled human monoclonal antibody (HB4C5), specific to lung cancer, into transplanted human lung cancer in nude mouse. In: Murakami H. (Ed). Trends in Animal Cell Culture Technology, Kodansha (1990), VCH, Tokyo 167-172
13. Hatziantoniou S., Dimas K., Georgopoulos A., Sotiriadou N., and Demetzos C. Cytotoxic and anti-tumor activity of liposome-incorporated sclareol against cancer cell lines and human colon cancer xenografts. Pharm. Res. 53 (2006) 80-87
14. Hori K., Sato Y., Ito K., Fujiwara Y., Iwamoto Y., Makino H., and Kawakubo A. Strict specificity for high-mannose type N-glycans and primary structure of a red alga Eucheuma serra lectin. Glycobiology 17 (2007) 479-491
15. Inoue K. Phosphatidylcholine (lecithin). In: Yamakawa T., and Nojima S. (Eds). Seikagaku Jikken Kouza vol. 3 (1974), Shishitsu no Kagaku, Tokyo Kagaku Dojin, Tokyo 257-258
16. Ioannou Y.A., and Chen F.W. Quantitation of DNA fragmentation in apoptosis. Nucleic Acids Res. 24 (1996) 992-993
17. Karasaki Y., Tsukamoto S., Mizusaki K., Sugiura T., and Gotoh S. A garlic lectin exerted an anti-tumor activity and induced apoptosis in human tumor cells. Food Res. Int. 34 (2001) 7-13
18. Kato K., and Hirashita J. Preparation and function of a hybrid-type vesicle modified by Concanavalin A for a DDS directed toward a cancer therapy. Proceeding of the 4th Asia-Pacific Biochemical Engineering Conference (APBioChEC'97). Beijing, 10-23 October 1997 (1997) 592-596
19. Kato K., and Hirata K. Water permeability through the lipid membrane of a giant vesicle prepared by a two-step emulsification technique. Solv. Extr. Res. Dev. Jpn. 3 (1996) 62-78
20. Kato K., Ikeda T., and Shinozaki M. Lipid membrane characteristic of large lipid vesicles prepared by two-step emulsification technique and enzymatic NAD + -recycling in the vesicles. J. Chem. Eng. Jpn. 26 (1993) 212-216
21. Kato K., Walde P., Mitsui H., and Higashi N. Enzymatic activity and stability of D-fructose dehydrogenase and sarcosine dehydrogenase immobilized onto giant vesicles. Biotechnol. Bioeng. 84 4 (2003) 415-423
22. Kato K., Walde P., Koine N., Imai Y., Akiyama K., and Sugahara T. Molecular composition of nonionic vesicles prepared from span 80 or span 85 by a two-step emulsification method. J. Dispersion Sci. Technol. 27 (2006) 1217-1222
23. Kato K., Walde P., Koine N., Ichikawa S., Nagahama T.R., Ishihara T., Tsujii T., Shudou M., Omokawa Y., and Kuroiwa T. Temperature-sensitive nonionic vesicles prepared from Span 80 (sorbitan monooleate). Langmuir 24 (2008) 10762-10770
24. Kawakubo A., Makino H., Ohnishi J., Hirohara H., and Hori K. The marine red alga Eucheuma serra J. Agardh, a high yielding source of two Isolectins. J. Appl. Phycol. 9 (1997) 331-338
25. Koning G.A., Kamps J.A.A.M., and Scherphof G.L. Efficient intracellular delivery of 5-fluorodeoxyuridine into colon cancer cells by targeted immunoliposomes. Cancer Detect. Prev. 26 (2002) 299-307
26. Konopka K., Pretzer E., Felgner P.L., and Düzgüneş N. Human immunodeficiency virus type-1 (HIV-1) infection increases the sensitivity of macrophages and THP-1 cells to cytotoxicity by cationic liposomes. Biochim. Biophys. Acta - Mol. Cell Res. 1312 (1996) 186-196
27. Korde A., Venkatesh M., Sarma H.D., and Pillai M.R.A. Preparation and pharmacokinetic evaluation of iodine-125 labeled alphamethyl-l-tyrosine. J. Radioanal. Nucl. Chem. 246 (2000) 173-178
28. 125I-labeled anti-epidermal growth factor receptor-vIII single-chain Fv exhibits specific and high-level targeting of glioma xenografts. Clin. Cancer Res. 5 (1999) 1539-1549
29. Larsson J., Wingardh K., Berggard T., Davies J.R., Logdberg L., Strand S.E., and Akerstrom B. Distribution of iodine 125-labeled α1-microglobulin in rats after intravenous injection. J. Lab. Clin. Med. 137 (2001) 165-175
30. Lian T., and Ho R.J.Y. Trends and developments in liposome drug delivery systems. J. Pharm. Sci. 90 (2001) 667-680
31. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
32. Martin S.J., Reutelingsperger C.P.M., McGahon A.J., Rader J.A., Van Schie R.C.A.A., LaFace D.M., and Green D.R. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by over expression of Bcl-2 and Abl. J. Exp. Med. 182 (1995) 1545-1556
33. Maruyama K., Takizawa T., Takahashi N., Tagawab T., Nagaikeb K., and Iwatsuru M. Targeting efficiency of PEG-immunoliposome-conjugated antibodies terminals. Adv. Drug Deliv. Rev. 24 (1997) 235-242
34. Ohama Y., Heike Y., Sugahara T., Sakata K., Yoshimura N., Hisaeda Y., Hosokawa M., Takashima S., and Kato K. Gene transfection into HeLa Cells by vesicles containing cationic peptide lipid. Biosci. Biotechnol. Biochem. 69 (2005) 1453-1458
35. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., and Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2 (2007) 751-760
36. Rad F.H., Le Buanec H., Paturance S., Larcier P., Genne P., Ryffel B., Bensussan A., Bizzini B., Gallo R.C., Zagury D., and Uzan G. VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 2837-2842
37. Sato T., Sunamoto J., Ishii N., and Koji K. Polysaccharide-coated immunoliposomes bearing anti-CEA Fab' fragment and their internalization by CEA-producing tumor cells. J. Bioact. Compat. Polym. 3 (1988) 195-204
38. Sharma A., and Sharma U.S. Liposomes in drug delivery: progress and limitations. Int. J. Pharm. 154 (1997) 123-140
39. Shirai T., Watanabe Y., Lee M., Ogawa T., and Muramoto K. Structure of Rhamnose-binding Lectin CSL3: unique pseudo-tetrameric architecture of a pattern recognition protein. J. Mol. Biol. 391 (2009) 390-403
40. Sugahara T., Ohama Y., Fukuda A., Hayashi M., Kawakubo A., and Kato K. The cytotoxic effect of Eucheuma serra agglutinin (ESA) on cancer cells and its application to molecular probe for drug delivery system using lipid vesicles. Cytotechnology 36 (2001) 93-99
41. Sugahara T., Kawashima S., Oda A., Hisaeda Y., and Kato K. Preparation of cationic immunovesicles containing cationic peptide lipid for specific drug delivery to target cells. Cytotechnology 47 (2005) 51-57
42. Timoshenko A.V., Lan Y., Gabius H.J., and Lala P.K. Immunotherapy of C3H/HeJ mammary adenocarcinoma with interleukin-2, mistletoe lectin or their combination: effects on tumor growth, capillary leakage and nitric oxide (NO) production. Eur. J. Cancer 37 (2001) 1910-1920
43. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4 (2005) 145-160
44. Wang H., Gao J., and Ng T.B. A new lectin with highly potent antihepatoma and antisarcoma activities from the oyster mushroom Pleurotus ostreatus. Biochem. Biophys. Res. Commun. 275 (2000) 810-816
45. Zeisig R., Shimada K., Hirota S., and Arndt D. Effect of sterical stabilization on macrophage uptake in vitro and on thickness of the fixed aqueous layer of liposomes made from alkylphosphocholines. Biochim. Biophys. Acta 1285 (1996) 237-245